New hope for men with recurrent prostate cancer: Ultra-Precise radiation shows promise
NCT ID NCT03253744
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tested a special type of radiation called stereotactic body radiation therapy (SBRT) in 17 men whose prostate cancer returned after earlier radiation. The treatment delivers high doses of radiation in just 5 sessions over 2 weeks, targeting only the tumor. The goal was to find the highest safe dose and see what side effects occur. Participants were followed for 2 years after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.